Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Kappos

Showing results (21-30 of 603) with videos related to

Pageof 61
Sort By:
Neurology|July 2, 2010
Measuring disability in relapsing-remitting MSRichard A Rudick, Ludwig Kappos
Neurology|March 26, 2008
Is natalizumab overshooting its rebound?Robert J Fox, Ludwig Kappos
Journal of the Neurological Sciences|April 22, 2006
Retraining attention in MSIris-Katharina Penner, Ludwig Kappos
Nature Reviews. Neurology|June 27, 2022
Development and implementation of new diagnostic technologies in neurologyCristina Granziera, Tim Woelfle, Ludwig Kappos
JAMA Neurology|December 19, 2022
Time to Change the Current Clinical Classification of Multiple Sclerosis?Cristina Granziera, Tobias Derfuss, Ludwig Kappos
Current Neurology and Neuroscience Reports|July 27, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directionsMatthias Mehling, Ludwig Kappos, Tobias Derfuss
Lancet (London, England)|February 1, 2003
Competing interests in multiple sclerosis researchJohn Noseworthy, Ludwig Kappos, Martin Daumer
Expert Review of Clinical Pharmacology|December 14, 2012
Teriflunomide for oral therapy in multiple sclerosisAthina Papadopoulou, Ludwig Kappos, Till Sprenger
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Otto van Eikema Hommes - 7 February 1932 - 16 August 2022Ludwig Kappos, Frederik Barkhof, Bernard Uitdehaag
Expert Review of Molecular Diagnostics|December 5, 2006
Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatmentRaija L P Lindberg, Ludwig Kappos
Pageof 61

Showing results (21-30 of 603) with videos related to

Sort By:
Pageof 61
Neurology|July 2, 2010
Measuring disability in relapsing-remitting MSRichard A Rudick, Ludwig Kappos
Neurology|March 26, 2008
Is natalizumab overshooting its rebound?Robert J Fox, Ludwig Kappos
Journal of the Neurological Sciences|April 22, 2006
Retraining attention in MSIris-Katharina Penner, Ludwig Kappos
Nature Reviews. Neurology|June 27, 2022
Development and implementation of new diagnostic technologies in neurologyCristina Granziera, Tim Woelfle, Ludwig Kappos
JAMA Neurology|December 19, 2022
Time to Change the Current Clinical Classification of Multiple Sclerosis?Cristina Granziera, Tobias Derfuss, Ludwig Kappos
Current Neurology and Neuroscience Reports|July 27, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directionsMatthias Mehling, Ludwig Kappos, Tobias Derfuss
Lancet (London, England)|February 1, 2003
Competing interests in multiple sclerosis researchJohn Noseworthy, Ludwig Kappos, Martin Daumer
Expert Review of Clinical Pharmacology|December 14, 2012
Teriflunomide for oral therapy in multiple sclerosisAthina Papadopoulou, Ludwig Kappos, Till Sprenger
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2022
Otto van Eikema Hommes - 7 February 1932 - 16 August 2022Ludwig Kappos, Frederik Barkhof, Bernard Uitdehaag
Expert Review of Molecular Diagnostics|December 5, 2006
Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatmentRaija L P Lindberg, Ludwig Kappos
Pageof 61